Precipio, Inc.
No enriched coverage for $PRPO in the last 7 days.
No SEC Form 4 filings for $PRPO in the last 30 days.
See all $PRPO insider activity →Precipio, Inc. (PRPO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001043961 0001043961 2026-06-15 2026-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of repo
Precipio Inc. (NASDAQ:PRPO) shares fell below their 200-day moving average during Wednesday trading, trading as low as $23.44 and last at $23.55. The 200-day average is $25.08. The article cites recent analyst changes, including a downgrade to “hold” by Wall Street Zen and “sell” ratings from Weiss. Precipio reported May 14 quarterly EPS of ($0.81) on $6.71M revenue.
SANDBERG RICHARD A sold 900 indirectly-held shares of Precipio, Inc. (PRPO) at $25.02 on 2026-05-21.
Recent PRPO coverage spans financial news, corporate actions and market movers.
Routine annual meeting results; modest governance/audit continuity signal with limited direct financial impact.
Technical breakdown below the 200-day MA, alongside predominantly bearish analyst ratings, increases near-term risk of further selling.
Insider selling is a modest negative signal, but the trade is small and under a stated 10b5-1 plan is not indicated.
Precipio's preliminary Q4 revenue growth suggests improved financial health, potentially supporting a bullish outlook for the stock.
Precipio (PRPO) reported strong Q3 2025 results with increased revenue, positive cash flow, and improved margins, indicating operational strength and potential for stock appreciation.
alphai scores every news story that mentions PRPO with an AI model for sentiment and relevance, and aggregates insider trades from Precipio, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Precipio, Inc. (PRPO) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. false 0001043961 0001043961 2026-06-15 2026-06-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of repo
2 min readPrecipio Inc. (NASDAQ:PRPO) shares fell below their 200-day moving average during Wednesday trading, trading as low as $23.44 and last at $23.55. The 200-day average is $25.08. The article cites recent analyst changes, including a downgrade to “hold” by Wall Street Zen and “sell” ratings from Weiss. Precipio reported May 14 quarterly EPS of ($0.81) on $6.71M revenue.
3 min readSANDBERG RICHARD A sold 900 indirectly-held shares of Precipio, Inc. (PRPO) at $25.02 on 2026-05-21.
1 min readPrecipio, a blood cancer diagnostics firm, announced a preliminary 23% increase in its fourth-quarter revenue. This short report, distributed by Reuters, highlights the company's Q4 financial performance.
2 min readPRPO reports strong third-quarter 2025 results with higher revenue, positive cash flow and improved margins in core divisions.
2 min readOver $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter ...
2 min readConference Call to be held on November 17th, 2025 at 5:00 PM EST Conference Call to be held on November 17th, 2025 at 5:00 PM EST ...
2 min readHSBC, American Express, TotalEnergies, Armanino Foods, and Precipio stand out in Zacks' latest research highlights.
3 min readNEW HAVEN, Conn., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Specialty cancer diagnostics company Precipio, Inc. PRPO, has terminated its ATM ( At-The-Market ) instrument with investment bank Alliance Global Partners ( AGP ) .
2 min readManagement Decision Further Reinforces Commitment to Responsible Capital Management Management Decision Further Reinforces Commitment to Responsible Capital Management ...
2 min read
